Thiotepa/Cyclophosphamide/Tbi as a Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndrome

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1704451
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of Cyclophosphamide-Tbi Versus Chemotherapy Alone as Conditioning Prior to Allogeneic Stem Cell Transplantation in Patients With AML

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

A Fludarabine-Based Dose-Reduced Conditioning Regimen Followed by Allogeneic Stem Cell Transplantation From Related or Unrelated Donors in Patients With Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2001English

Haploidentical Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

A Reduced-Intensity Conditioning Regimen for Patients With Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Thiotepa and Fractionated TBI Conditioning Prior to Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies: A Phase II Single Institution Trial

Bone Marrow Transplantation
TransplantationHematology
2004English

Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Decitabine Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Intermediate- And High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft Versus Host Disease

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Hematopoietic Stem Cell Transplantation for Childhood Myeloid Malignancies After High-Dose Thiotepa, Busulfan and Cyclophosphamide

Bone Marrow Transplantation
TransplantationHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy